Antioxidants have no effect on Lou Gehrig's disease
A review of recent studies suggests that antioxidant supplements, including vitamin E and selenium, do not prolong the survival of patients with amyotrophic lateral sclerosis, or Lou Gehrig's disease....... Although antioxidant treatments do not appear to cause any problems for ALS patients, they do not prevent muscle deteroriation or improve the quality of life for these patients, according to D...Olfactory bulb stem cells and Lou Gehrig's disease
Johns Hopkins researchers have found that transplants of mouse stem cells taken from the adult brain's olfactory bulb can delay symptoms and death in a mouse model of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. They are scheduled to present their findings Oct. 24 at the annual meeting of the Society for Neuroscience in San Diego....... The olfactory bulb, the center of smell det...Human spinal cord cells help rats with Lou Gehrig's disease
Human primitive spinal cord cells delayed symptoms and paralysis by a week when implanted in the spinal cord of rats destined to develop amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, researchers from Johns Hopkins report.... ...The human neuronal stem cells were obtained from embryos by scientists at biotech company Neurostem Inc., transferred to Hopkins and implanted into the low...First biomarkers to diagnose Lou Gehrig's disease found in CNS
A University of Pittsburgh pathologist has identified the first protein biomarkers able to diagnose patients with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease) with near 100 percent accuracy. Before this finding, there were no known diagnostic biomarkers for this neurodegenerative disease. ...... As a result, diagnosis typically takes from six to 12 months after patient...Lipid abnormalities linked to Lou Gehrigs disease
Abnormal accumulation of two common lipids in motor nerve cells could play a critical role in the development of amyotrophic lateral sclerosis (ALS), according to investigators at the National Institute on Aging (NIA) in Baltimore. The finding could help scientists develop drugs and other treatments that might one day slow or arrest the disease's progression. ..."ALS is a terrible disease in whic...Researchers identify pathway that may slow the progression of Lou Gehrig's disease
............ Columbia researchers have participated in a new study that points toward a potential treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. ... The study, led by Dr. Robert M. Friedlander of Harvard Medical School and the Brigham and Women's Hospital Neuroapoptosis Laboratory and Neurosurgical Service, will be published in the April 14 issue of Scienc...